Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth C Inzaule

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Lancet. HIV|October 5, 2018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySeth C Inzaule, Raph L Hamers, Marc Noguera-Julian, et al.
AIDS (London, England)|September 27, 2023
First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothersKesner Francois, Joelle Deas Van Onacker, Michael R Jordan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 30, 2017
High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in NigeriaSeth C Inzaule, Samuels J Osi, Gbenga Akinbiyi, et al.
Scientific Reports|October 27, 2018
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistanceSeth C Inzaule, Cissy M Kityo, Margaret Siwale, et al.
AIDS (London, England)|July 18, 2020
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan AfricaSeth C Inzaule, Silvia Bertagnolio, Cissy M Kityo, et al.
AIDS (London, England)|July 23, 2020
Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low-income and middle-income countriesSeth C Inzaule, Michael R Jordan, Amandine Cournil, et al.
AIDS (London, England)|May 23, 2020
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan AfricaSeth C Inzaule, Michael R Jordan, George Bello, et al.
AIDS (London, England)|May 24, 2022
Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysisSeth C Inzaule, Stefanie Kroeze, Cissy M Kityo, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2018
Association between HIV-1 subtype and drug resistance in Nigerian infantsBeth Chaplin, Alani Sulaimon Akanmu, Seth C Inzaule, et al.
African Journal of Laboratory Medicine|November 7, 2022
Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, NigeriaJoseph Anejo-Okopi, Edith Okeke, Pantong M Davwar, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. HIV|October 5, 2018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control studySeth C Inzaule, Raph L Hamers, Marc Noguera-Julian, et al.
AIDS (London, England)|September 27, 2023
First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothersKesner Francois, Joelle Deas Van Onacker, Michael R Jordan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 30, 2017
High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in NigeriaSeth C Inzaule, Samuels J Osi, Gbenga Akinbiyi, et al.
Scientific Reports|October 27, 2018
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistanceSeth C Inzaule, Cissy M Kityo, Margaret Siwale, et al.
AIDS (London, England)|July 18, 2020
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan AfricaSeth C Inzaule, Silvia Bertagnolio, Cissy M Kityo, et al.
AIDS (London, England)|July 23, 2020
Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low-income and middle-income countriesSeth C Inzaule, Michael R Jordan, Amandine Cournil, et al.
AIDS (London, England)|May 23, 2020
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan AfricaSeth C Inzaule, Michael R Jordan, George Bello, et al.
AIDS (London, England)|May 24, 2022
Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysisSeth C Inzaule, Stefanie Kroeze, Cissy M Kityo, et al.
The Journal of Antimicrobial Chemotherapy|September 28, 2018
Association between HIV-1 subtype and drug resistance in Nigerian infantsBeth Chaplin, Alani Sulaimon Akanmu, Seth C Inzaule, et al.
African Journal of Laboratory Medicine|November 7, 2022
Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, NigeriaJoseph Anejo-Okopi, Edith Okeke, Pantong M Davwar, et al.
Pageof 4